Sort
10,829 grants matching “car t”
Childhood Cancer Data Initiative
$3,444,819Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZID · FY2023 · CA
TLE transcription cofactors in anti-viral and anti-tumor immunity
$3,436,588Hai-Hui Xue · Hackensack University Medical Center · R01 · FY2025 · AI
CD5-deleted chimeric antigen receptor cells (Senza5 CART5) to enhance immunotherapy against T cell non-Hodgkin lymphoma (NHL): a first-in-human phase I clinical trial
$3,421,591Stefan Klaus Barta · University Of Pennsylvania · R01 · FY2025 · FD
Implementing and Personalizing Best-In-Class Opioid-sparing Pain Management for Major Inpatient Surgeries in Children
$3,404,830Senthilkumar Sadhasivam · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · HD
Lipid and Lipoprotein Metabolism in Atherosclerosis
$3,378,947University Of California Los Angeles · P01 · FY2004 · HL
Collaborative Research: Expeditions in Computing: The Science of Deep Specification
$3,375,811Stephanie C Weirich · University Of Pennsylvania · · FY2015 · CSE
Retroviral Mediated Gene Transfer Into Primate Hematopoietic Cells
$3,371,856So Gun Hong · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Metabolic reprogramming of tumor microenvironment to maximize immunotherapy for pediatric cancers
$3,370,657Ruoning Wang · Research Inst Nationwide Children'S Hosp · U01 · FY2018 · CA
Designer Tregs for restoring tolerance in patients with type 1 diabetes
$3,351,746Jeffrey A Bluestone · University Of California, San Francisco · UC4 · FY2017 · DK
Mechanisms and biological consequences of the nuclear receptor CAR activation
$3,347,197Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Toward development of senolytic CAR T cells
$3,326,400Scott W Lowe · Sloan-Kettering Inst Can Research · RF1 · FY2025 · AG
Implementing and Personalizing Best-In-Class Opioid-sparing Pain Management for Major Inpatient Surgeries in Children
$3,315,439Senthilkumar Sadhasivam · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · HD
Multimodal PET-CT imaging of SIVmac239 dynamics post-ART interruption
$3,302,677Afamefuna Okoye · Oregon Health & Science University · R01 · FY2025 · AI
Mathematics Instruction using Decision Science and Engineering Tools
$3,301,292Robert E Young · North Carolina State University · · FY2007 · EDU
Mechanisms and biological consequences of the nuclear receptor CAR activation
$3,293,801Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
CyberCorps SFS Renewal: Accelerated Undergraduate/Graduate CyberScholars Program
$3,286,927Amos L Abbott · Virginia Polytechnic Institute And State University · · FY2020 · EDU
Lipid and Lipoprotein Metabolism in Atherosclerosis
$3,270,696University Of California Los Angeles · P01 · FY2003 · HL
Collaborative Research: FEC: Optical Properties of Mineral Dust Aerosols: Building Capacity for Use-Inspired Applications Through Experimental and Theoretical Investigations
$3,260,118Hans Moosmuller · Nevada System Of Higher Education, Desert Research Institute · · FY2025 · O/D
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT
$3,253,754Richard Schrock · Fisher Bioservices, Inc. · N02 · FY2023 · CA
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$3,252,811Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
B7-H3-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY FOR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)
$3,246,139The General Hospital Corporation · · FY2020 · Defense Health Agency
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
$3,119,164Carl H. June · University Of Pennsylvania · P01 · FY2024 · CA
SPORE in Lymphoma
$3,109,934Helen E Heslop · Baylor College Of Medicine · P50 · FY2025 · CA
WNPRC ANIMAL SERVICES DIVISION
$3,098,062Saverio Vincent Capuano · University Of Wisconsin-Madison · P51 · FY2010 · RR
SPORE in Lymphoma
$3,097,657Helen E Heslop · Baylor College Of Medicine · P50 · FY2017 · CA